ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nitschke, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nitschke, R
Annals of Clinical and Laboratory Science, Vol 11, Issue 5, 392-396
Copyright © 1981 by Association of Clinical Scientists

Articles

Renal complications of cis-diamminedichloroplatinum

R Nitschke

The use of cis-diamminedichloroplatinum II (DDP), an active agent against special cancer types, is limited by its nephrotoxicity. It damages the proximal tubular epithelium and may cause specific tubular dysfunctions, such as elevation of enzymes and 2 beta microglobulin in the urine or, under special conditions, low calcium and/or magnesium serum concentrations. Cis-diamminedichloroplatinum II produces acute renal failure which can be prevented by hydration. The value of diuretics in preventing renal failure is not determined and needs to be evaluated further.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the Association of Clinical Scientists.